| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 373.07M | 330.48M | 271.82M | 232.34M | 191.91M | 151.53M |
| Gross Profit | 279.55M | 247.96M | 194.37M | 166.06M | 139.25M | 111.24M |
| EBITDA | 31.09M | 12.55M | -10.66M | -30.12M | -52.25M | -14.38M |
| Net Income | -8.43M | -29.09M | -21.73M | -41.63M | -35.22M | -17.00M |
Balance Sheet | ||||||
| Total Assets | 700.13M | 519.05M | 442.58M | 415.53M | 388.74M | 169.05M |
| Cash, Cash Equivalents and Short-Term Investments | 430.14M | 290.90M | 226.88M | 229.81M | 270.63M | 70.10M |
| Total Debt | 11.59M | 16.53M | 14.72M | 16.74M | 0.00 | 0.00 |
| Total Liabilities | 256.99M | 248.11M | 217.74M | 172.38M | 133.17M | 148.87M |
| Stockholders Equity | 443.13M | 269.15M | 210.60M | 229.15M | 250.35M | 17.13M |
Cash Flow | ||||||
| Free Cash Flow | 103.00M | 85.85M | 31.17M | -6.24M | 2.57M | 18.10M |
| Operating Cash Flow | 110.49M | 88.89M | 34.69M | -774.00K | 5.03M | 19.12M |
| Investing Cash Flow | -30.35M | -2.60M | -5.65M | -21.45M | -3.38M | 1.37M |
| Financing Cash Flow | 147.08M | -15.54M | -33.67M | -17.15M | 198.62M | 35.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| ― | $2.19B | 23.51 | 13.86% | ― | 13.02% | -2.57% | |
| ― | $4.25B | 50.98 | 10.03% | ― | 20.51% | 12.84% | |
| ― | $3.59B | 30.98 | ― | ― | 13.29% | 79.98% | |
| ― | $3.67B | ― | -12.60% | ― | 11.41% | 33.76% | |
| ― | $3.16B | ― | -2.60% | ― | 24.41% | 40.20% | |
| ― | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
| ― | $4.47B | ― | -81.98% | ― | 20.48% | -44.22% |
AvePoint, Inc. has recently been involved in a share offering, with UBS AG, Singapore Branch acting as the Stabilizing Manager. The company has seen a significant number of shares purchased and has ceased price stabilization actions as of October 17, 2025. Additionally, the over-allotment option was partially exercised to cover shares that were over-allotted, with the closing of this exercise expected around October 24, 2025.
AvePoint, Inc. has announced the secondary listing of its shares on the main board of the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acting as the Stabilizing Manager, has purchased 9,240 shares of AvePoint’s common stock in the open market at a price of S$18.10. This move is part of the stabilizing actions in relation to the offering of AvePoint’s shares, which could potentially enhance the company’s market presence and investor confidence in the region.
AvePoint, Inc. has announced the secondary listing of its common stock shares on the Main Board of the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acting as the Stabilizing Manager, has purchased 1,590 shares at a price of S$18.86 to support the offering. This move is part of AvePoint’s strategy to expand its market presence and enhance liquidity for its shares, potentially benefiting stakeholders by increasing the stock’s accessibility and visibility in the Asian market.
UBS AG’s Singapore Branch, acting as the Stabilizing Manager, announced the purchase of 147,310 shares of AvePoint, Inc. on the open market. This action is part of the secondary listing of AvePoint’s shares on the Singapore Exchange’s main board, indicating a strategic move to stabilize the stock price and potentially enhance investor confidence in the company’s market presence.
AvePoint, Inc. has announced the stabilization actions related to the secondary listing of its shares on the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acting as the Stabilizing Manager, has purchased 510 shares of AvePoint’s common stock in the open market at a price of S$18.84. This move is part of the company’s efforts to support the offering and maintain the stability of its share price during the listing process.
AvePoint, Inc. has announced the secondary listing of its shares on the main board of the Singapore Exchange Securities Trading Limited (SGX-ST). As part of this process, UBS AG, Singapore Branch, acting as the Stabilizing Manager, has purchased 13,910 shares of AvePoint’s common stock in the open market at a price of S$19.50. This stabilizing action is part of the company’s efforts to ensure a smooth transition and stable trading environment for its shares on the SGX-ST.
UBS AG Singapore Branch has announced a stabilizing action regarding the secondary listing of AvePoint, Inc.’s shares on the Singapore Exchange. On October 9, 2025, UBS purchased 1,610 shares of AvePoint at a price of S$19.50 each, which is part of their role as the Stabilizing Manager to support the stock’s market performance.
UBS AG Singapore Branch has announced stabilizing actions related to AvePoint, Inc.’s secondary listing on the Singapore Exchange. On October 6, 2025, UBS AG purchased 4,480 shares of AvePoint’s common stock at a price of S$19.32 per share. This move is part of the efforts to stabilize the stock’s market performance following its listing, which could impact AvePoint’s market presence and investor confidence.
UBS AG’s Singapore Branch has announced a stabilizing action related to the secondary listing of AvePoint, Inc.’s shares on the Singapore Exchange’s main board. As the Stabilizing Manager, UBS AG purchased 5,850 shares of AvePoint’s common stock in the open market, with the price ranging from S$18.96 to S$19.11. This action is part of efforts to support the stock’s market price following its listing, which could impact AvePoint’s market presence and investor confidence.
AvePoint, Inc. has announced the secondary listing of its shares on the Main Board of the Singapore Exchange Securities Trading Limited (SGX-ST). As part of this process, UBS AG’s Singapore Branch, acting as the Stabilizing Manager, has purchased 241,090 shares of AvePoint’s common stock in the open market at a price of S$18.95. This move is part of the stabilizing actions related to the offering, which may impact AvePoint’s market presence and investor confidence in the region.
AvePoint, Inc. has announced the secondary listing of its common stock shares on the Main Board of the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acting as the Stabilizing Manager, has purchased 126,740 shares in the open market at a price of S$19.34 per share. This move is part of the company’s strategic efforts to stabilize the stock price and enhance its market presence in Singapore.
AvePoint, Inc. has announced the secondary listing of its shares on the main board of the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acting as the Stabilizing Manager, purchased 86,790 shares of AvePoint’s common stock at a price of S$19.50 per share to support the offering. This move is part of AvePoint’s strategic efforts to enhance its market presence and liquidity in the Asian financial markets.
AvePoint, Inc. has announced the stabilization action in relation to the secondary listing of its shares on the Main Board of the Singapore Exchange Securities Trading Limited (SGX-ST). UBS AG, Singapore Branch, acting as the Stabilizing Manager, has purchased 35,300 shares of AvePoint’s common stock at a price of S$19.50 to support the offering. This move is part of the company’s strategy to ensure a stable market for its shares, potentially enhancing investor confidence and market positioning.
The most recent analyst rating on (AVPT) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on AvePoint stock, see the AVPT Stock Forecast page.
AvePoint, Inc. has announced the secondary listing of its shares on the Singapore Exchange Securities Trading Limited (SGX-ST) Main Board. The shares, which are already listed on the Nasdaq Global Select Market under the ticker ‘AVPT’, were priced at US$15.96 as of September 18, 2025. This move is expected to broaden AvePoint’s market presence and provide more liquidity options for investors, although it does not guarantee a liquid market.
The most recent analyst rating on (AVPT) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on AvePoint stock, see the AVPT Stock Forecast page.
AvePoint, Inc. has announced a registered public offering of 13,290,360 shares of its common stock, with an over-allotment option of up to 1,993,550 additional shares. This offering, conducted under a Form S-3 registration statement, is set to be settled on the Singapore Exchange Securities Trading Limited. The Monetary Authority of Singapore has granted a stabilization exemption to facilitate this offering, which could potentially enhance AvePoint’s market presence and liquidity by broadening its investor base.
The most recent analyst rating on (AVPT) stock is a Buy with a $22.00 price target. To see the full list of analyst forecasts on AvePoint stock, see the AVPT Stock Forecast page.
AvePoint, Inc. recently held its earnings call, showcasing a robust performance with record-breaking revenue and notable growth across key metrics. The sentiment during the call was overwhelmingly positive, with the company highlighting significant achievements in its SaaS and ARR segments. Despite facing challenges such as a decline in term license revenue and foreign exchange headwinds, the overall momentum and strategic advancements were emphasized as strong positives.
AvePoint, Inc., a leader in data security, governance, and resilience, provides solutions that enable organizations to manage their data across various collaboration platforms. The company recently announced its second quarter 2025 financial results, marking a significant milestone with total quarterly revenue exceeding $100 million for the first time. This achievement underscores AvePoint’s strategic growth and innovation in the AI-driven data management landscape.